Verve Therapeutics, Inc closed the private placement of 2,296,317 shares at an issue price of price of $10 per share on December 1, 2023.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.36 USD | +4.61% | +3.41% | -54.38% |
Stocks mentioned in the article
Price
|
Change
|
5d. change
|
Capi.
| ||
---|---|---|---|---|---|
771.6 USD | -0.45% | +2.07% | 695B | ||
6.36 USD | +4.61% | +3.41% | 534M | ||
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-54.38% | 534M | |
+23.37% | 47.02B | |
+50.07% | 41.86B | |
-0.94% | 41.76B | |
-4.32% | 28.8B | |
+11.29% | 26.05B | |
-20.92% | 19.15B | |
+3.20% | 12.55B | |
-2.67% | 11.82B | |
+30.23% | 12.34B |
- Stock Market
- Equities
- VERV Stock
- News Verve Therapeutics, Inc.
- Verve Therapeutics, Inc. announced that it has received $22.96317 million in funding from Eli Lilly and Company